Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News Drax advances UK’s first new pumped storage hydro scheme in decades with Voith Hydro partnership Drax, a leader in renewable energy, has taken a significant step towards enhancing the UK’s energy infrastructure by… byPallavi MadhirajuJuly 9, 2024